After being elected to the Board of Directors, Meaghan Loy participated in a virtual roundtable discussion with fellow NA3RsC members to seek out ways the group can help further its commitment to refine, reduce and replace animals used in research.

Tech Snapshot® captures today’s cutting-edge tools and technologies that will help drive drug discovery tomorrow. This installment was written by Yvette Stallwood, Ph.D., Head of Applied Protein Services, Lonza Biologics.

Tech Snapshot® captures today’s cutting-edge tools and technologies that will help drive drug discovery tomorrow. This installment was written by IMCS.

Tech Snapshot® captures today’s cutting-edge tools and technologies that will help drive drug discovery tomorrow. This installment was written by Sekisui XenoTech, whose mission is to improve the health and welfare of society and future generations by supporting sustainable development of life-saving therapies through science grounded in excellence and quality. 

As businesses begin to reopen, including laboratories, researchers should expect operations to look slightly different. Based on conversations we’ve had with existing partners and recent literature, here are some of the proposed changes for projects that must be done in person: